Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience

Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience

Abstract Background Current management of poorly draining complex effusions favours less invasive image-guided placement of smaller tubes and adjunctive intrapleural fibrinolysis therapy (IPFT). In MIST-2 trial, intrapleural 10 mg alteplase (t-PA) with 5 mg of pulmozyme (DNase) twice daily for 72 h...

Full description

Bibliographic Details
Main Authors: Xiong Khee Cheong, Andrea Yu-Lin Ban, Boon Hau Ng, Nik Nuratiqah Nik Abeed, Nik Azuan Nik Ismail, Nik Farhan Nik Fuad, Syed Zulkifli Syed Zakaria, Sheah Lin Ghan, Mohamed Faisal Abdul Hamid
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Pulmonary Medicine
Subjects:
Intrapleural fibrinolysis
Pleural infection
Empyema
Alteplase
DNase
Online Access:https://doi.org/10.1186/s12890-022-01995-z

Internet

https://doi.org/10.1186/s12890-022-01995-z

Similar Items